JP2010523469A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523469A5
JP2010523469A5 JP2009534901A JP2009534901A JP2010523469A5 JP 2010523469 A5 JP2010523469 A5 JP 2010523469A5 JP 2009534901 A JP2009534901 A JP 2009534901A JP 2009534901 A JP2009534901 A JP 2009534901A JP 2010523469 A5 JP2010523469 A5 JP 2010523469A5
Authority
JP
Japan
Prior art keywords
antibody
amino acid
immunoconjugate
seq
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009534901A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523469A (ja
JP5394246B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/082726 external-priority patent/WO2008052187A2/en
Publication of JP2010523469A publication Critical patent/JP2010523469A/ja
Publication of JP2010523469A5 publication Critical patent/JP2010523469A5/ja
Application granted granted Critical
Publication of JP5394246B2 publication Critical patent/JP5394246B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009534901A 2007-03-30 2007-10-26 抗体及びイムノコンジュゲートとこれらの使用方法 Active JP5394246B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US92130007P 2007-03-30 2007-03-30
US60/921,300 2007-03-30
US93785707P 2007-06-29 2007-06-29
US60/937,857 2007-06-29
PCT/US2007/082726 WO2008052187A2 (en) 2006-10-27 2007-10-26 Antibodies and immunoconjugates and uses therefor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013217609A Division JP5837019B2 (ja) 2007-03-30 2013-10-18 抗体及びイムノコンジュゲートとこれらの使用方法

Publications (3)

Publication Number Publication Date
JP2010523469A JP2010523469A (ja) 2010-07-15
JP2010523469A5 true JP2010523469A5 (enExample) 2010-12-16
JP5394246B2 JP5394246B2 (ja) 2014-01-22

Family

ID=42575819

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009534901A Active JP5394246B2 (ja) 2007-03-30 2007-10-26 抗体及びイムノコンジュゲートとこれらの使用方法
JP2013217609A Active JP5837019B2 (ja) 2007-03-30 2013-10-18 抗体及びイムノコンジュゲートとこれらの使用方法
JP2015217734A Active JP6185540B2 (ja) 2007-03-30 2015-11-05 抗体及びイムノコンジュゲートとこれらの使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013217609A Active JP5837019B2 (ja) 2007-03-30 2013-10-18 抗体及びイムノコンジュゲートとこれらの使用方法
JP2015217734A Active JP6185540B2 (ja) 2007-03-30 2015-11-05 抗体及びイムノコンジュゲートとこれらの使用方法

Country Status (1)

Country Link
JP (3) JP5394246B2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5990947A (ja) * 1982-11-16 1984-05-25 Matsushita Electronics Corp 半導体装置
ES2874306T3 (es) * 2010-09-29 2021-11-04 Agensys Inc Conjugados de anticuerpos y fármacos (CAF) que se unen a las proteínas 191P4D12
US8987209B2 (en) * 2010-09-29 2015-03-24 Seattle Genetics, Inc. N-carboxyalkyl-auristatin and the use thereof
AU2011326564A1 (en) * 2010-11-10 2013-05-09 Genentech, Inc. Methods and compositions for neural disease immunotherapy
HUE031017T2 (en) * 2011-04-01 2017-06-28 Wyeth Llc Antibody Drug Conjugates
EP2780039B9 (en) 2011-11-17 2018-04-18 Pfizer Inc Cytotoxic peptides and antibody drug conjugates thereof
US20130143237A1 (en) * 2011-11-29 2013-06-06 Genentech, Inc. Compositions and methods for prostate cancer analysis
AU2012376421A1 (en) * 2012-04-04 2014-11-13 Perseus Proteomics Inc. Drug conjugate comprising anti-cdh3 (p-cadherin) antibody
CN112587671A (zh) * 2012-07-18 2021-04-02 博笛生物科技有限公司 癌症的靶向免疫治疗
EP3964237B1 (en) * 2013-03-15 2026-02-18 Regeneron Pharmaceuticals, Inc. Biologically active molecules, conjugates thereof, and therapeutic uses
EP3092256B1 (en) * 2014-01-10 2022-05-18 Birdie Biopharmaceuticals Inc. Compounds and compositions for immunotherapy
WO2015112909A1 (en) * 2014-01-24 2015-07-30 Genentech, Inc. Methods of using anti-steap1 antibodies and immunoconjugates
TWI731535B (zh) * 2014-03-21 2021-06-21 美商艾伯維有限公司 抗-egfr抗體及抗體藥物結合物
SG10202102467RA (en) 2014-07-24 2021-04-29 Genentech Inc Methods of conjugating an agent to a thiol moiety in a protein that contains at least one trisulfide bond
WO2017055388A2 (en) * 2015-10-02 2017-04-06 F. Hoffmann-La Roche Ag Bispecific t cell activating antigen binding molecules
FI3817770T3 (fi) * 2018-07-02 2026-07-06 Amgen Inc Antigeeniä sitova anti-steap1-proteiini
CN111655295B (zh) 2018-08-29 2024-05-28 荣昌生物制药(烟台)股份有限公司 抗her2抗体药物偶联物在治疗尿路上皮癌中的用途
EA202191201A1 (ru) 2018-12-03 2022-01-26 Эдженсис, Инк. Фармацевтические композиции, включающие конъюгаты анти-191p4d12 антитело-лекарственное средство, и способы их применения
US20230097908A1 (en) * 2020-01-22 2023-03-30 Medimmune Limited Compounds and conjugates thereof
CN111494645B (zh) * 2020-05-20 2022-09-30 中国药科大学 抗人dll4人源化抗体与美登素生物碱dm1的偶联物及其制备方法与应用
CN117750980A (zh) * 2021-05-24 2024-03-22 荣昌生物制药(烟台)股份有限公司 Her2靶向抗体-药物偶联物用于治疗her2低表达乳腺癌的用途
US12533419B2 (en) 2021-07-19 2026-01-27 Mabplex International Co., Ltd. Antibody drug conjugate loaded with binary toxins and its application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE456578T1 (de) * 1999-12-06 2010-02-15 Agensys Inc Serpentinetransmembranrezeptoren exprimiert in menschlichem prostatakrebs und ihre verwendungen
BRPI0418766B8 (pt) * 2004-04-22 2021-05-25 Agensys Inc anticorpo ou seu fragmento, vetor, composição farmacêutica, ensaio e método para detectar a presença de proteína steap-1, bem como método para distribuir um agente citotóxico ou um agente de diagnóstico
TR201808537T4 (tr) * 2004-09-23 2018-07-23 Genentech Inc Sistein değiştirilmiş antikorlar ve konjugatlar.

Similar Documents

Publication Publication Date Title
RU2483080C2 (ru) Антитела и иммуноконъюгаты и их применение
JP2016063817A5 (enExample)
JP2013056896A5 (enExample)
RU2423382C1 (ru) Композиции и способы диагностики и лечения опухоли
RU2008141171A (ru) Анти-тат226 антитела и иммуноконъюгаты
JP2014139173A5 (enExample)
JP2012522512A5 (enExample)
JP2012522513A5 (enExample)
JP2023179713A5 (enExample)
JP2015528818A5 (enExample)
JP2017110002A5 (enExample)
JP2019031565A5 (enExample)
JP2015523380A5 (enExample)
RU2011144141A (ru) АНТИТЕЛА К FcRH5, ИХ ИММУНОКОНЪЮГАТЫ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
JP2015523961A5 (enExample)
RU2011144119A (ru) АНТИТЕЛА К FcRH5, ИХ ИММУНОКОНЪЮГАТЫ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
JP2016523810A5 (enExample)
JP2016528882A5 (enExample)
JP2012519711A5 (enExample)
IL311145B2 (en) Antibody drug conjugates (adc) that bind to 191p4d12 proteins
IL295449A (en) Cycteine engineering anti-cd79b antibodies and antibody-drug conjugates
JP2015527318A5 (enExample)
RU2011140491A (ru) Конъюгаты антитело-лекарственное средство, которые связывают белки 24р4с12
RU2014148162A (ru) Анти-pmel17 антитела и их иммуноконъюгаты
JP2016098233A5 (enExample)